169 related articles for article (PubMed ID: 21642744)
1. Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis.
Ge X; Yin L; Ma H; Li T; Chiang JY; Zhang Y
J Lipid Res; 2011 Aug; 52(8):1561-8. PubMed ID: 21642744
[TBL] [Abstract][Full Text] [Related]
2. The aldo-keto reductase Akr1b7 gene is a common transcriptional target of xenobiotic receptors pregnane X receptor and constitutive androstane receptor.
Liu MJ; Takahashi Y; Wada T; He J; Gao J; Tian Y; Li S; Xie W
Mol Pharmacol; 2009 Sep; 76(3):604-11. PubMed ID: 19542321
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes.
Volle DH; Repa JJ; Mazur A; Cummins CL; Val P; Henry-Berger J; Caira F; Veyssiere G; Mangelsdorf DJ; Lobaccaro JM
Mol Endocrinol; 2004 Apr; 18(4):888-98. PubMed ID: 14739254
[TBL] [Abstract][Full Text] [Related]
4. AKR1B7 is induced by the farnesoid X receptor and metabolizes bile acids.
Schmidt DR; Schmidt S; Holmstrom SR; Makishima M; Yu RT; Cummins CL; Mangelsdorf DJ; Kliewer SA
J Biol Chem; 2011 Jan; 286(4):2425-32. PubMed ID: 21081494
[TBL] [Abstract][Full Text] [Related]
5. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.
Zhang Y; Lee FY; Barrera G; Lee H; Vales C; Gonzalez FJ; Willson TM; Edwards PA
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1006-11. PubMed ID: 16410358
[TBL] [Abstract][Full Text] [Related]
6. knocking down liver ccaat/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice.
Qiao L; MacLean PS; You H; Schaack J; Shao J
Endocrinology; 2006 Jun; 147(6):3060-9. PubMed ID: 16543372
[TBL] [Abstract][Full Text] [Related]
7. ER stress-induced adipocytes secrete-aldo-keto reductase 1B7-containing exosomes that cause nonalcoholic steatohepatitis in mice.
Gu H; Yang K; Shen Z; Jia K; Liu P; Pan M; Sun C
Free Radic Biol Med; 2021 Feb; 163():220-233. PubMed ID: 33359683
[TBL] [Abstract][Full Text] [Related]
8. A novel inhibitory protein in adipose tissue, the aldo-keto reductase AKR1B7: its role in adipogenesis.
Tirard J; Gout J; Lefrançois-Martinez AM; Martinez A; Begeot M; Naville D
Endocrinology; 2007 May; 148(5):1996-2005. PubMed ID: 17272390
[TBL] [Abstract][Full Text] [Related]
9. Activation of the glucocorticoid receptor or liver X receptors interferes with growth hormone-induced akr1b7 gene expression in rat hepatocytes.
Kotokorpi P; Gardmo C; Nyström CS; Mode A
Endocrinology; 2004 Dec; 145(12):5704-13. PubMed ID: 15358674
[TBL] [Abstract][Full Text] [Related]
10. Steroidogenic factor-1 controls the aldose reductase akr1b7 gene promoter in transgenic mice through an atypical binding site.
Martinez A; Val P; Sahut-Barnola I; Aigueperse C; Veyssière G; Lefrançois-Martinez AM
Endocrinology; 2003 May; 144(5):2111-20. PubMed ID: 12697720
[TBL] [Abstract][Full Text] [Related]
11. Aldo-keto reductase 1b7, a novel marker for renin cells, is regulated by cyclic AMP signaling.
Lin EE; Pentz ES; Sequeira-Lopez ML; Gomez RA
Am J Physiol Regul Integr Comp Physiol; 2015 Sep; 309(5):R576-84. PubMed ID: 26180185
[TBL] [Abstract][Full Text] [Related]
12. Identification of a role for a mouse sperm surface aldo-keto reductase (AKR1B7) and its human analogue in the detoxification of the reactive aldehyde, acrolein.
Jagoe WN; Howe K; O'Brien SC; Carroll J
Andrologia; 2013 Oct; 45(5):326-31. PubMed ID: 22970857
[TBL] [Abstract][Full Text] [Related]
13. Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist.
Zhao T; Wang J; He A; Wang S; Chen Y; Lu J; Lv J; Li S; Wang J; Qian M; Li H; Shen X
Metabolism; 2021 Jun; 119():154771. PubMed ID: 33831422
[TBL] [Abstract][Full Text] [Related]
14. Bile acids as regulators of hepatic lipid and glucose metabolism.
Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
[TBL] [Abstract][Full Text] [Related]
15. The aldo-keto reductase AKR1B7 coexpresses with renin without influencing renin production and secretion.
Machura K; Iankilevitch E; Neubauer B; Theuring F; Kurtz A
Am J Physiol Renal Physiol; 2013 Mar; 304(5):F578-84. PubMed ID: 23303406
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.
Zhang HM; Wang X; Wu ZH; Liu HL; Chen W; Zhang ZZ; Chen D; Zeng TS
Mol Med Rep; 2016 Mar; 13(3):2135-42. PubMed ID: 26782298
[TBL] [Abstract][Full Text] [Related]
17. Adrenal tumorigenesis targeted by the corticotropin-regulated promoter of the aldo-keto reductase AKR1B7 gene in transgenic mice.
Sahut-Barnola I; Lefrancois-Martinez AM; Jean C; Veyssiere G; Martinez A
Endocr Res; 2000 Nov; 26(4):885-98. PubMed ID: 11196467
[TBL] [Abstract][Full Text] [Related]
18. FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model.
Kunne C; Acco A; Duijst S; de Waart DR; Paulusma CC; Gaemers I; Oude Elferink RP
Biochim Biophys Acta; 2014 May; 1842(5):739-46. PubMed ID: 24548803
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor agonist decreases lipid accumulation by promoting hepatic fatty acid oxidation in db/db mice.
Liu Y; Song A; Yang X; Zhen Y; Chen W; Yang L; Wang C; Ma H
Int J Mol Med; 2018 Sep; 42(3):1723-1731. PubMed ID: 29901078
[TBL] [Abstract][Full Text] [Related]
20. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
